News
-
-
-
Fosun International Announces 2020 Annual Results: Total Revenue Amounted to RMB136.6 Billion, Gathering Strength to Fuel Growth
2021-03-30
Total revenue amounted to RMB136.6 billion. Net profit attributable to owners of the parent was RMB8.02 billion. Industrial operating profit reached RMB8.15 billion.
-
-
-
-
Rapid Reaction and Adaptation to the Pandemic, To Be a Socially Responsible Real Estate Investment Owner and Manager
2021-03-26
Now Is The Time To Embrace ESG Responsible Investing
-
-
-
-
BioNTech and Fosun Pharma Jointly Announce the Arrival of the First Batch of COVID-19 mRNA Vaccine in Hong Kong and Macau
2021-02-27Fosun Pharma
The first batch of COVID-19 mRNA vaccine COMIRNATY® (also known as BNT162b2, Chinese product name: 復必泰TM) has arrived in Hong Kong.
-
-
-
-
MOODY’S ASSIGNS FIRST-TIME A3 IFSR TO FIDELIDADE MACAU
2021-01-22
Macao, January 12, 2021 – Yesterday, Moody’s Investors Service (Moody’s) assigned an A3 insurance financial strength rating (IFSR) to Fidelidade Macau - Insurance Company Limited (Fidelidade Macau), an important achievement that reflects the company’s strong underwriting profitability and capitalization, along with its prudent investment allocation. The outloo
-
-
-
-
Henlius Daratumumab Biosimilar Received IND Approval from NMPA
2021-01-13
-
-
-
-
Enjoy French Snow Holiday, Reinventing Togetherness with a New Start – new snow mountain experiences in Club Med Yabuli
2020-12-30
-
-
-
-
NMPA Has Accepted The NDA of HLX01 (Rituximab Injection) for the Treatment of Rheumatoid Arthritis
2020-12-17
-
-
-
-
Henlius Adalimumab Biosimilar 汉达远® Approved by NMPA
2020-12-10
-
-
-
-
Hauck & Aufhäuser takes first step towards digital assets
2020-10-09
-
